Developmental Origins of Health and Disease: Environmental Exposures

The developmental origins of health and disease (DOHaD) approach has evolved over the past 20 years, and the current hypothesis proposes that fetal adaptations to intrauterine and maternal conditions during development shape structure and function of organs. Here we present a review of some environmental exposures that may trigger fetal maladaptations in these processes, including three examples: exposures to tobacco smoke, antidepressant medication, and folic acid deficits in the food supply. We provide a selected review of current research on the effects of each of these exposures on fetal development and birth outcomes, and use the DOHaD approach to suggest how these exposures may alter long-term outcomes. In the interpretation of this literature, we review the evidence of gene-environment interactions based on evaluation of biological pathways and evidence that some exposures to the fetus may be moderated by maternal and fetal genotypes. Finally, we use the design of the National Children's Study (now in progress) to propose how the DOHaD approach could be used to address questions that have emerged in this area that are relevant to reproductive medicine and subsequent health outcomes.

[1]  哲郎 小川,et al.  Developmental Origins of Health and Disease説の責任遺伝子の網羅的検索 , 2011 .

[2]  J. Stockman Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs , 2011 .

[3]  J. Stockman In Utero Smoke Exposure, Glutathione S-transferase P1 Haplotypes, and Respiratory Illness–Related Absence Among Schoolchildren , 2011 .

[4]  J. Hirschhorn Genomewide association studies--illuminating biologic pathways. , 2009, The New England journal of medicine.

[5]  Claudia Buss,et al.  Developmental Origins of Health and Disease: Brief History of the Approach and Current Focus on Epigenetic Mechanisms , 2009, Seminars in reproductive medicine.

[6]  K. Meador,et al.  Antiepileptic drug use in women of childbearing age , 2009, Epilepsy & Behavior.

[7]  M. Järvelin,et al.  Smoking during pregnancy and hyperactivity-inattention in the offspring--comparing results from three Nordic cohorts. , 2009, International journal of epidemiology.

[8]  T. Wilt,et al.  Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[9]  Matthew S. Goodwin,et al.  Maternal Smoking During Pregnancy and Neonatal Behavior: A Large-Scale Community Study , 2009, Pediatrics.

[10]  F. Malone,et al.  Preconceptional Folate Supplementation and the Risk of Spontaneous Preterm Birth: A Cohort Study , 2009, PLoS medicine.

[11]  G. Dekker,et al.  Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study , 2009, BMJ : British Medical Journal.

[12]  S. Hernández-Díaz,et al.  Selective serotonin reuptake inhibitor use and risk of gestational hypertension. , 2009, The American journal of psychiatry.

[13]  Gustavo Turecki,et al.  Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse , 2009, Nature Neuroscience.

[14]  S. Gentile,et al.  Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine. , 2009, The Journal of clinical psychiatry.

[15]  G. Koren,et al.  Adverse effects in neonates exposed to SSRIs and SNRI in late gestation--Motherisk Update 2008. , 2009, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[16]  James Swanson,et al.  Developmental origins of child mental health disorders. , 2008, Journal of child psychology and psychiatry, and allied disciplines.

[17]  Kent L Thornburg,et al.  Effect of in Utero and Early-life Conditions on Adult Health and Disease Epidemiol Ogic a Nd Clinic a L Observations , 2022 .

[18]  Patrick O. McGowan,et al.  Promoter-Wide Hypermethylation of the Ribosomal RNA Gene Promoter in the Suicide Brain , 2008, PloS one.

[19]  C. Hertzman,et al.  Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: Population-based study , 2008, British Journal of Psychiatry.

[20]  Michael Weitzman,et al.  Prenatal tobacco smoke and postnatal secondhand smoke exposure and child neurodevelopment , 2008, Current opinion in pediatrics.

[21]  Xiping Xu,et al.  Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on G×E interactions and pathogenic pathways , 2008, Human Genetics.

[22]  Min Shi,et al.  Review on genetic variants and maternal smoking in the etiology of oral clefts and other birth defects. , 2008, Birth defects research. Part C, Embryo today : reviews.

[23]  Gabriele Bolte,et al.  Parental smoking and childhood obesity--is maternal smoking in pregnancy the critical exposure? , 2008, International journal of epidemiology.

[24]  M. Gillman,et al.  Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis , 2008, International Journal of Obesity.

[25]  T. Coleman,et al.  Environmental tobacco smoke and fetal health: systematic review and meta-analysis , 2008, Archives of Disease in Childhood Fetal and Neonatal Edition.

[26]  L. Shulman Evaluation of Fetal and Maternal Genetic Variation in the Progesterone Receptor Gene for Contributions to Preterm Birth , 2008 .

[27]  T. Porter,et al.  In utero tobacco exposure is associated with modified effects of maternal factors on fetal growth. , 2008, American journal of obstetrics and gynecology.

[28]  Xiping Xu,et al.  The joint association between F5 gene polymorphisms and maternal smoking during pregnancy on preterm delivery , 2008, Human Genetics.

[29]  C. Rotimi,et al.  Adverse Birth Outcome Among Mothers With Low Serum Cholesterol , 2007, Pediatrics.

[30]  M. Marazita,et al.  Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery , 2007, Journal of Perinatology.

[31]  R. Waterland,et al.  Epigenetic epidemiology of the developmental origins hypothesis. , 2007, Annual review of nutrition.

[32]  R. Todd,et al.  Prenatal Smoking Exposure and Dopaminergic Genotypes Interact to Cause a Severe ADHD Subtype , 2007, Biological Psychiatry.

[33]  W. Reik Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.

[34]  A. Hofman,et al.  Maternal smoking and fetal growth characteristics in different periods of pregnancy: the generation R study. , 2007, American journal of epidemiology.

[35]  B. Haight,et al.  Bupropion in pregnancy and the prevalence of congenital malformations , 2007, Pharmacoepidemiology and drug safety.

[36]  T. Einarson,et al.  Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. , 2007, Clinical therapeutics.

[37]  S. Gentile,et al.  Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review , 2007, Human psychopharmacology.

[38]  E. Gilpin,et al.  The California Tobacco Control Program’s effect on adult smokers: (1) Smoking cessation , 2007, Tobacco Control.

[39]  P. Brocklehurst,et al.  Common antiepileptic drugs in pregnancy in women with epilepsy , 2007 .

[40]  H. Dolk,et al.  Should Europe fortify a staple food with folic acid? , 2007, The Lancet.

[41]  B. J. Casey,et al.  Etiologic Subtypes of Attention-Deficit/Hyperactivity Disorder: Brain Imaging, Molecular Genetic and Environmental Factors and the Dopamine Hypothesis , 2007, Neuropsychology Review.

[42]  P. Gluckman,et al.  Non‐genomic transgenerational inheritance of disease risk , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.

[43]  L. Bakhireva,et al.  Effect of Maternal Asthma and Gestational Asthma Therapy on Fetal Growth , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.

[44]  Min Shi,et al.  Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants. , 2007, American journal of human genetics.

[45]  P. Auinger,et al.  Exposures to Environmental Toxicants and Attention Deficit Hyperactivity Disorder in U.S. Children , 2006, Environmental health perspectives.

[46]  Liza S. Rovniak,et al.  Reducing the Gap between the Economic Costs of Tobacco and Funds for Tobacco Training in Schools of Public Health , 2006, Public health reports.

[47]  R. Weksberg,et al.  Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. , 2006, Placenta.

[48]  B. Källén,et al.  Antidepressant drugs during pregnancy and infant congenital heart defect. , 2006, Reproductive toxicology.

[49]  B. Tycko,et al.  Imprinted genes in placental growth and obstetric disorders , 2006, Cytogenetic and Genome Research.

[50]  S. Hernández-Díaz,et al.  Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn , 2006, The New England journal of medicine.

[51]  R. Waterland,et al.  Maternal Genistein Alters Coat Color and Protects Avy Mouse Offspring from Obesity by Modifying the Fetal Epigenome , 2006, Environmental health perspectives.

[52]  R. Casper Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors: Literature Review and Implications for Clinical Applications , 2006 .

[53]  M. Gillman Developmental origins of health and disease. , 2005, The New England journal of medicine.

[54]  A. Berghold,et al.  Preventing neural tube defects in Europe: a missed opportunity. , 2005, Reproductive toxicology.

[55]  F. Perera,et al.  A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures. , 2005, Neurotoxicology.

[56]  M. Meaney,et al.  Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome , 2005, Dialogues in clinical neuroscience.

[57]  G. Smith,et al.  Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review. , 2005, Paediatric and perinatal epidemiology.

[58]  P. Gluckman,et al.  Living with the Past: Evolution, Development, and Patterns of Disease , 2004, Science.

[59]  W. Dean,et al.  Epigenetic reprogramming during early development in mammals. , 2004, Reproduction.

[60]  D. Skalnik,et al.  Histone deacetylase activity is required for embryonic stem cell differentiation , 2004, Genesis.

[61]  C. Hales,et al.  Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis , 1992, Diabetologia.

[62]  J. Lumley,et al.  Interventions for promoting smoking cessation during pregnancy. , 2004, The Cochrane database of systematic reviews.

[63]  A. Toschke,et al.  Early intrauterine exposure to tobacco-inhaled products and obesity. , 2003, American journal of epidemiology.

[64]  Theodore P Rasmussen,et al.  Reproductive Biology and Endocrinology Open Access Embryonic Stem Cell Differentiation: a Chromatin Perspective Embryonic Stem Cells: Promise and Challenge , 2022 .

[65]  Robert A. Waterland,et al.  Transposable Elements: Targets for Early Nutritional Effects on Epigenetic Gene Regulation , 2003, Molecular and Cellular Biology.

[66]  B. Lanphear,et al.  Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors. , 2003, The Journal of pediatrics.

[67]  Tianhua Niu,et al.  Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. , 2002, JAMA.

[68]  J. Mackay,et al.  The Tobacco Atlas , 2002 .

[69]  B. Coull,et al.  The Teratogenicity of Anticonvulsant Drugs , 2001 .

[70]  T. J. Mathews,et al.  Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. , 2001, JAMA.

[71]  N. Thomson,et al.  Asthma in pregnancy. , 2000, The American journal of medicine.

[72]  B. Eskenazi,et al.  Association of prenatal maternal or postnatal child environmental tobacco smoke exposure and neurodevelopmental and behavioral problems in children. , 1999, Environmental health perspectives.

[73]  K. Jones,et al.  Birth outcomes in pregnant women taking fluoxetine. , 1996, New England Journal of Medicine.

[74]  D. Haig,et al.  Genetic Conflicts in Human Pregnancy , 1993, The Quarterly Review of Biology.

[75]  P. Gluckman,et al.  Fetal nutrition and cardiovascular disease in adult life , 1993, The Lancet.

[76]  R. Windsor,et al.  The impact on infant birth weight and gestational age of cotinine-validated smoking reduction during pregnancy. , 1993, JAMA.

[77]  J Olsen,et al.  Cigarette smoking in pregnancy and fetal growth. Does the type of tobacco play a role? , 1992, International journal of epidemiology.

[78]  L. Berstein,et al.  WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASE , 1989, The Lancet.

[79]  C. Osmond,et al.  INFANT MORTALITY, CHILDHOOD NUTRITION, AND ISCHAEMIC HEART DISEASE IN ENGLAND AND WALES , 1986, The Lancet.

[80]  M. Susser,et al.  Obesity in young men after famine exposure in utero and early infancy. , 1976, The New England journal of medicine.

[81]  J. Yerushalmy,et al.  The relationship of parents' cigarette smoking to outcome of pregnancy--implications as to the problem of inferring causation from observed associations. , 1971, American journal of epidemiology.

[82]  W. Simpson,et al.  A preliminary report on cigarette smoking and the incidence of prematurity. , 1957, American journal of obstetrics and gynecology.

[83]  T. R. Forbes,et al.  Human Embryology , 1946, The Yale Journal of Biology and Medicine.